1. Home
  2. AEHL vs BDRX Comparison

AEHL vs BDRX Comparison

Compare AEHL & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AEHL

Antelope Enterprise Holdings Limited

HOLD

Current Price

$1.63

Market Cap

2.0M

Sector

Industrials

ML Signal

HOLD

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$3.29

Market Cap

2.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHL
BDRX
Founded
1993
2000
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
2.0M
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
AEHL
BDRX
Price
$1.63
$3.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.5M
182.7K
Earning Date
05-04-2026
09-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.60
52 Week High
$6.53
$11.88

Technical Indicators

Market Signals
Indicator
AEHL
BDRX
Relative Strength Index (RSI) 47.28 49.13
Support Level $0.84 $2.97
Resistance Level $2.20 $4.39
Average True Range (ATR) 1.10 0.39
MACD 0.01 -0.14
Stochastic Oscillator 21.00 10.59

Price Performance

Historical Comparison
AEHL
BDRX

About AEHL Antelope Enterprise Holdings Limited

Antelope Enterprise Holdings Ltd operates in three reportable operating segments: Business Management Consulting, information system technology consulting services including the sales of software use rights for digital data deposit platforms and asset management systems, and online social media platform development and consulting; Natural Gas Power generation, which was in the initial development stage; and Live-Streaming e-commerce segment, providing a one-stop solution for customers to enable them to utilize the growing sales channel of livestreaming ecommerce. The business of the Company is engaged in the PRC and the United States.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: